Our Firm is representing hundreds of women who allegedly suffered serious vaginal mesh complications due to products manufactured by Ethicon and other companies, including many whose claims are pending in the federal litigation.
New York, NY (PRWEB) May 16, 2014
The federal judge overseeing thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against Johnson & Johnson’s Ethicon, Inc. unit has sanctioned the companies’ attorneys for removing certain cases to federal court, despite numerous rulings that the lawsuits belong in a Pennsylvania litigation. According to court documents, the lawsuits in question named Pennsylvania-based Secant Medical Inc. as a defendant, and were originally filed in the Philadelphia Court of Common Pleas. In an Order issued on May 13, 2014, U.S. District Judge Joseph R. Goodwin of the Southern District of West Virginia wrote that the defense attempts to move the cases, despite repeated rulings that Secant had not been fraudulently joined, were calculated “to keep these cases out of state court for as long as possible and to waste the court's time and the plaintiff's resources.” (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)
“Our Firm is representing hundreds of women who allegedly suffered serious vaginal mesh complications due to products manufactured by Ethicon and other companies, including many whose claims are pending in the federal litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate transvaginal mesh lawsuits on behalf of women who suffered serious complications, allegedly due to products marketed by Ethicon and other manufacturers.
Ethicon Transvaginal Mesh Lawsuits
Court documents indicate that more than 18,000 transvaginal mesh lawsuits have been filed in the Southern District of West Virginia on behalf of women who were allegedly injured by Ethicon devices used in the treatment of pelvic organ prolapse and stress urinary incontinence. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in that proceeding. All of the complaints allege that the use of these devices caused thousands of women to suffer mesh erosion, chronic pain, organ damage and other serious, and sometimes permanent, vaginal mesh complications.
Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March with a jury awarding $11 million in compensatory and punitive damages to a woman who was harmed by the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
According to court records, more than 55,000 transvaginal mesh lawsuits have been filed against a number of device manufacturers in litigations that are underway in the Southern District of West Virginia. Mr. Grand is also serving on the Plaintiffs’ Steering Committees in proceedings involving : American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
Alleged victims of vaginal mesh complications may be entitled to file their own transvaginal mesh lawsuit. To learn more about the litigation involving these devices, please visit Bernstein Liebhard LLP, or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter
Felecia L. Stern, Esq.
Bernstein Liebhard LLP